Finance & valuation

Latest content

How platform technologies are reshaping life sciences IP value creation

Versatile biotechnologies are changing patterns of collaboration among healthcare innovators

10 February 2022

Buyer and seller can be pleased with the BlackBerry patent sale’s outcome

The Canadian company has secured another three years’ worth of income from an encumbered portfolio, while the buyers can take high-quality assets into new markets

03 February 2022

GSK lands one of the biggest patent settlements of all time

The billion-dollar-plus agreement shows the astronomical financial value that individual pharmaceutical patents can have

03 February 2022

Big tech dominates brand value rankings led by $355 billion Apple portfolio

Tech sector brand assets gained significant value over the past year, according to the latest Brand Finance Global 500

31 January 2022

CRISPR IP deals continue apace despite legal battles

Spate of recent transactions show the value of gene-editing patents beyond Cas9

28 January 2022

Building blocks for the metaverse – practical IP considerations for NFT investors and creators

Nader Mousavi, Mehdi Ansari, Jay Thornton and Jonathan Hofman of Sullivan & Cromwell explore the legal issues facing creators and buyers of NFTs, alongside the regulatory frameworks in which they are being used

19 January 2022

BlackBerry patent sale almost there but still not over the line

“We are literally down to the last few important items now,” says company CEO John Chen on Q3 earnings call

22 December 2021

It’s a big 48 hours for BlackBerry and the patent market in general

The company is due to release its Q3 financials tomorrow, but it is not known whether the touted sale of a portfolio of well over 30,000 individual assets will also be announced

20 December 2021

IAM insight panel analysis Q4 2021

Featured in Community Insight

The president’s choice for director of the agency sees uptick in positive sentiment towards the administration’s policies in the survey findings for IAM’s Q4 Panel Report

09 December 2021

Australia under-invests in IP, and recent government proposals will not fix that

Saturday Opinion: In-house leaders say a mooted patent box regime limited to life sciences will reward companies that get patents already, failing to encourage IP investment in new industries

04 December 2021

Unlock unlimited access to all IAM content